PTC Therapeutics (PTCT)
NASDAQ:PTCT
Holding PTCT?
Track your performance easily

PTC Therapeutics (PTCT) Financial Statements

315 Followers

PTC Therapeutics Financial Overview

PTC Therapeutics's market cap is currently ―. The company's EPS TTM is $-6.317; its P/E ratio is -5.55; PTC Therapeutics is scheduled to report earnings on October 24, 2024, and the estimated EPS forecast is $-1.51. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 186.70M$ 210.12M$ 307.06M$ 196.58M$ 174.59M
Gross Profit$ 186.70M$ 210.12M$ 277.94M$ 196.58M$ 213.81M
EBIT$ -85.73M$ -69.96M-$ -166.59M$ -237.48M
EBITDA$ -72.04M$ -16.17M-$ -101.48M$ -183.18M
Net Income Common Stockholders$ -99.18M$ -76.84M$ -155.79M$ -113.98M$ -198.88M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.09B$ 884.81M$ 876.74M$ 294.81M$ 337.94M
Total Assets$ 1.92B$ 1.79B$ 1.90B$ 1.26B$ 1.34B
Total Debt$ 395.50M$ 421.44M$ 415.03M$ 704.35M$ 702.68M
Net Debt$ -697.79M$ -463.37M$ -461.71M$ 409.54M$ 364.74M
Total Liabilities$ 2.90B$ 2.68B$ 2.71B$ 1.93B$ 1.92B
Stockholders Equity$ -980.15M$ -893.92M$ -818.55M$ -670.82M$ -579.25M
Cash Flow-
Free Cash Flow$ -36.04M$ 6.41M-$ -45.23M$ 95.50M
Operating Cash Flow$ -71.45M$ 70.76M$ -100.29M$ -16.02M$ 114.78M
Investing Cash Flow$ -65.92M$ -114.93M$ -94.42M$ -28.10M$ -152.65M
Financing Cash Flow$ 246.48M$ 540.00K$ 620.49M$ 3.36M$ 18.46M
Currency in USD

PTC Therapeutics Earnings and Revenue History

PTC Therapeutics Debt to Assets

PTC Therapeutics Cash Flow

PTC Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis